Gregory Gene Freitag

Gregory Gene Freitag has an estimated net worth of $14.8 Million. This is based on reported shares across multiple companies, which include Axogen, Inc., PDS Biotechnology Corp, PRESSURE BIOSCIENCES INC, and ZyVersa Therapeutics, Inc..

2021 was Gregory Gene Freitag's most active year for acquiring shares with 13 total transactions. Gregory Gene Freitag's most active month to acquire stocks was the month of May. 2021 was Gregory Gene Freitag's most active year for disposing of shares, totalling 11 transactions. Gregory Gene Freitag's most active month to dispose stocks was the month of April. 2021 saw Gregory Gene Freitag paying a total of $1,007,400.68 for 165,313 shares, this is the most they've acquired in one year. In 2018 Gregory Gene Freitag cashed out on 137,801 shares for a total of $2,340,120.75, their largest year based on trade value.